| scholarly article | Q13442814 |
| P2093 | author name string | Bo Jiang | |
| Tammy R Dugas | |||
| Karen Y Stokes | |||
| Alok R Khandelwal | |||
| Valeria Y Hebert | |||
| P2860 | cites work | Pharmacological basis for concentration-controlled therapy with zidovudine, lamivudine, and indinavir | Q28345258 |
| A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. | Q29035699 | ||
| Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice | Q35610718 | ||
| Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans | Q35980355 | ||
| Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia | Q35989704 | ||
| Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk | Q36468854 | ||
| Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors | Q40518202 | ||
| Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. | Q40882910 | ||
| Endothelial dysfunction in atherosclerosis. | Q41221374 | ||
| Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy | Q43556074 | ||
| A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | Q43613003 | ||
| One-step solid-phase extraction procedure for F(2)-isoprostanes. | Q43654415 | ||
| Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction | Q43678570 | ||
| Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors | Q43723992 | ||
| Trends in the prescription of antiretroviral drugs and impact on plasma HIV-RNA measurements | Q43754392 | ||
| Antiretrovirals induce direct endothelial dysfunction in vivo. | Q44083807 | ||
| Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. | Q44552097 | ||
| Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjects | Q44606717 | ||
| Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir | Q44807945 | ||
| Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine | Q45003754 | ||
| Effects of HIV drug combinations on endothelin-1 and vascular cell proliferation. | Q45061915 | ||
| Direct effects of nucleoside reverse transcriptase inhibitors on rat cardiac mitochondrial bioenergetics | Q46667580 | ||
| Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography | Q46890085 | ||
| Colour-Doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy: a comparative study. | Q53897720 | ||
| Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. | Q54066253 | ||
| Red and black rice decrease atherosclerotic plaque formation and increase antioxidant status in rabbits. | Q55034793 | ||
| Protease inhibitors and cardiovascular outcomes in patients with HIV-1 | Q57955538 | ||
| Mouse Models of Atherosclerosis | Q64357718 | ||
| HIV antiretroviral drug combination induces endothelial mitochondrial dysfunction and reactive oxygen species production, but not apoptosis | Q64377031 | ||
| Plasma lipid transfer proteins | Q68884684 | ||
| Variation in susceptibility to atherosclerosis among inbred strains of mice | Q69805944 | ||
| A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 | ||
| Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice | Q73707721 | ||
| Cardiomyopathy, nucleoside reverse transcriptase inhibitors and mitochondria are linked through AIDS and its therapy | Q81110657 | ||
| P433 | issue | 3 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| anti-retroviral agent | Q50430310 | ||
| P304 | page(s) | 164-171 | |
| P577 | publication date | 2009-03-09 | |
| P1433 | published in | Toxicology Letters | Q1796854 |
| P1476 | title | HIV-1 antiretrovirals induce oxidant injury and increase intima-media thickness in an atherogenic mouse model | |
| P478 | volume | 187 |
| Q30430542 | Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia |
| Q36104280 | Brain injury caused by HIV protease inhibitors: role of lipodystrophy and insulin resistance. |
| Q33901061 | Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction |
| Q43258132 | Management of hypertriglyceridaemia caused by combination antiretroviral therapy in HIV-infected patients: role of omega-3 polyunsaturated fatty acids at different dosages, compared with fibrates |
| Q34349192 | Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 mice |
| Q36701580 | Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones |
| Q46130631 | Nucleoside/nucleotide reverse transcriptase inhibitors attenuate angiogenesis and lymphangiogenesis by impairing receptor tyrosine kinases signalling in endothelial cells |
| Q35556516 | Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction. |
| Q37155953 | Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy |
| Q59353210 | Viral infection and atherosclerosis |
Search more.